Anna Mae Diehl
Duke University · 657 works · 70,151 citations · h-index 132
Top works
- Alcohollike liver disease in nonalcoholics
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States
- Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
- Metformin reverses fatty liver disease in obese, leptin-deficient mice
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- Nonalcoholic fatty liver disease
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- Leptin regulates proinflammatory immune responses
- Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
- Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
- Methylprednisolone Therapy in Patients with Severe Alcoholic Hepatitis
- A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity.
- Obesity Induces Expression of Uncoupling Protein-2 in Hepatocytes and Promotes Liver ATP Depletion
- Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- Clinical, Laboratory and Histological Associations in Adults with Nonalcoholic Fatty Liver Disease†
- Alterations in Liver ATP Homeostasis in Human Nonalcoholic Steatohepatitis
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota